Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia
Jane A. O’Halloran(St. Vincent's University Hospital), Michael A. Proschan(National Institute of Allergy and Infectious Diseases), Patricia Segura Nunez(Hospital Nacional Cayetano Heredia), Gerardo Capo(Trinitas Regional Medical Center), Radica Z. Alicic(Providence Health & Services), Stacey J. Adam(Foundation for the National Institutes of Health), Christopher Palma(University of Rochester), Emily R. Ko(Duke University Health System), Eduardo Sprinz(Hospital de Clínicas de Porto Alegre), Matthias Salathé(University of Miami), Kate Willsey(Cornell University), Thomas F. Patterson(National Institute of Allergy and Infectious Diseases), Jun Wen(The First People's Hospital of Changde), Anne M. Lachiewicz(University of North Carolina at Chapel Hill), Tatyana Der(Duke University Health System), Lisa M. LaVange(University of North Carolina at Chapel Hill), Richard Melsheimer(ISA Pharmaceuticals (Netherlands)), Adriana M. Rauseo(Washington University in St. Louis), Eyal Kedar(St. Lawrence University), Maria Patelli Juliani Souza Lima(Hospital e Maternidade Celso Pierro), Sabina Mendívil-Tuchía de Tai, Esteban C. Nannini(Centro Científico Tecnológico - Santa Fe), Susan Halabi(Duke Medical Center), Steven E. McNulty, Matthew W. McCarthy(Cornell University), William Ferguson(AbbVie (United States)), Pearl Zakroysky(Duke University), Sandra Butler(Technical Resources International (United States)), John Blamoun(MidMichigan Medical Center - Midland), Akram Khan(Oregon Health & Science University), Alfredo J Mena Lora(University of Illinois Chicago), Hussein R. Al‐Khalidi(Clinical Research Institute), Kevin J. Anstrom(University of North Carolina at Chapel Hill), Daniel González(Hospital Civil de Guadalajara), Horacio Ariza, Daniel K. Benjamin(Duke University), Analía Mykietiuk(Instituto Médico Platense), A Silverstein(Duke University), Soju Chang(National Center for Advancing Translational Sciences), Reynold A. Panettieri(Rutgers, The State University of New Jersey), Cameron R. Wolfe(Duke Medical Center), Martin Maillo(Centro Científico Tecnológico - Santa Fe), Jennifer Wang(University of Massachusetts Chan Medical School), Sean M. O’Brien(Duke University), Cynthia Gonzalez(National Center for Advancing Translational Sciences), Michael A. Maldonado(Bristol-Myers Squibb (United States)), Jane C. Atkinson(National Center for Advancing Translational Sciences), Luis Parra-Rodriguez(Washington University in St. Louis), P. Brian Smith(Duke University), Britta Witting(Cornell University)
Cited by 67
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k